S186: UPDATED RESULTS OF A MULTICENTER FIRST-IN-HUMAN STUDY OF BCMA/CD19 DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

• J. Du,
• H. Jiang,
• B. Dong,
• L. Gao,
• L. Liu,
• J. Ge,
• A. He,
• L. Li,
• J. Lu,
• X. Chen,
• M. Sersch,
• H. Zhang,
• L. Shen,
• J. Liu,
• W. Fu

Affiliations

J. Du

1 Changzheng Hospital, Shanghai

H. Jiang

1 Changzheng Hospital, Shanghai

B. Dong

2 Xijing Hospital, Xian

L. Gao

3 Chongqing Xinqiao hospital, Chongqing

L. Liu

4 Tangdu Hospital, Xian

J. Ge

5 The first affiliated hospital of Anhui medical University, Anhui

A. He

6 The second affiliated hospital of Xian Jiaotong University, Xian

L. Li

1 Changzheng Hospital, Shanghai

J. Lu

1 Changzheng Hospital, Shanghai

X. Chen

2 Xijing Hospital, Xian

M. Sersch

7 Gracellbiotechnologies Ltd, Shanghai, China

H. Zhang

7 Gracellbiotechnologies Ltd, Shanghai, China

L. Shen

7 Gracellbiotechnologies Ltd, Shanghai, China

J. Liu

7 Gracellbiotechnologies Ltd, Shanghai, China

W. Fu

1 Changzheng Hospital, Shanghai